QuantuMDx Diagnostic Test for SARS-CoV-2 Remains Suitable for the Detection of All Discovered Variants, Including VUI-202012/01

NEWCASTLE UPON TYNE, UK, Dec. 22 (Korea Bizwire) – QuantuMDx Group Limited (“QuantuMDx”), a UK-based life sciences company developing transformational point-of-care molecular diagnostics, today confirms its diagnostic assay for SARS-CoV-2 remains suitable for detecting all available virus strains, following the identification of a new strain of SARS-CoV-2. The UK COVID Genomics Consortium and Public Health [...]